DK1979321T3 - Nye pyridinylaminoalkylen- og pyridinyloxyalkylen-cyclopropanaminer, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende dissse - Google Patents
Nye pyridinylaminoalkylen- og pyridinyloxyalkylen-cyclopropanaminer, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende dissseInfo
- Publication number
- DK1979321T3 DK1979321T3 DK07730888T DK07730888T DK1979321T3 DK 1979321 T3 DK1979321 T3 DK 1979321T3 DK 07730888 T DK07730888 T DK 07730888T DK 07730888 T DK07730888 T DK 07730888T DK 1979321 T3 DK1979321 T3 DK 1979321T3
- Authority
- DK
- Denmark
- Prior art keywords
- pyridinyloxyalkylene
- pyridinylaminoalkylene
- cyclopropanamines
- diss
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0600784A FR2896800B1 (fr) | 2006-01-30 | 2006-01-30 | Nouveaux composes pyridinylaminoalkylene-et pyridinyloxyalkylene-cyclopropanamines polysubstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
PCT/FR2007/000170 WO2007085750A1 (fr) | 2006-01-30 | 2007-01-30 | Nouveaux composes pyridinylaminoalkylene- et pyridinyloxyalkylene- cyclopropanamines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1979321T3 true DK1979321T3 (da) | 2009-11-02 |
Family
ID=37102591
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK07730888T DK1979321T3 (da) | 2006-01-30 | 2007-01-30 | Nye pyridinylaminoalkylen- og pyridinyloxyalkylen-cyclopropanaminer, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende dissse |
Country Status (29)
Country | Link |
---|---|
US (1) | US20100317698A1 (ko) |
EP (1) | EP1979321B9 (ko) |
JP (1) | JP2009525311A (ko) |
KR (1) | KR101050910B1 (ko) |
CN (1) | CN101374814B (ko) |
AR (1) | AR059221A1 (ko) |
AT (1) | ATE437857T1 (ko) |
AU (1) | AU2007209235B2 (ko) |
BR (1) | BRPI0710443A2 (ko) |
CA (1) | CA2640482C (ko) |
CY (1) | CY1109477T1 (ko) |
DE (1) | DE602007001779D1 (ko) |
DK (1) | DK1979321T3 (ko) |
EA (1) | EA015227B1 (ko) |
ES (1) | ES2330899T3 (ko) |
FR (1) | FR2896800B1 (ko) |
GE (1) | GEP20105090B (ko) |
HK (1) | HK1126190A1 (ko) |
HR (1) | HRP20090523T1 (ko) |
MA (1) | MA30222B1 (ko) |
MY (1) | MY149068A (ko) |
NO (1) | NO20083753L (ko) |
PL (1) | PL1979321T3 (ko) |
PT (1) | PT1979321E (ko) |
RS (1) | RS51065B (ko) |
SI (1) | SI1979321T1 (ko) |
UA (1) | UA88116C2 (ko) |
WO (1) | WO2007085750A1 (ko) |
ZA (1) | ZA200806399B (ko) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2009303545A1 (en) * | 2008-10-14 | 2010-04-22 | Psychogenics, Inc | Nicotinic acetylcholine receptor ligands and the uses thereof |
US8975261B2 (en) | 2011-05-24 | 2015-03-10 | Merck Sharp & Dohme Corp. | Aryloxmethyl cyclopropane derivatives as PDE10 inhibitors |
BR112017004334A2 (pt) * | 2014-09-05 | 2018-08-07 | Celgene Quanticel Res Inc | inibidores de desmetilase específica de lisina-1. |
US20180311238A1 (en) * | 2017-04-28 | 2018-11-01 | Saniona A/S | Selective Agonist Of a6 Containing nAChRs |
CN110483392A (zh) * | 2018-05-14 | 2019-11-22 | 上海海和药物研究开发有限公司 | 合成n-保护的喹啉-7-基氧基甲基环丙基胺衍生物的方法及合成中间体 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU5326100A (en) * | 1999-06-07 | 2000-12-28 | Targacept, Inc. | Pharmaceutical compositions and methods for use |
JP2001261652A (ja) * | 2000-03-21 | 2001-09-26 | Suntory Ltd | 二置換イミノヘテロサイクリック化合物 |
FR2810664B1 (fr) * | 2000-06-27 | 2004-12-24 | Adir | Nouveaux composes cyclopropaniques 1,1 et 1,2-dissubstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US7098331B2 (en) * | 2003-03-05 | 2006-08-29 | Targacept, Inc. | Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
FR2889188B1 (fr) * | 2005-07-28 | 2007-09-07 | Servier Lab | Nouveaux composes 1,1-pyridinylaminocyclopropanamines polysubstitues, leur procede de preparation et les compositions phamaceutiques qui les contiennent |
FR2889187B1 (fr) * | 2005-07-28 | 2007-09-07 | Servier Lab | Nouveaux composes 1,1-pyridinyloxycyclopropanamines polysusbstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2006
- 2006-01-30 FR FR0600784A patent/FR2896800B1/fr not_active Expired - Fee Related
-
2007
- 2007-01-29 AR ARP070100362A patent/AR059221A1/es unknown
- 2007-01-30 RS RSP-2009/0450A patent/RS51065B/sr unknown
- 2007-01-30 DK DK07730888T patent/DK1979321T3/da active
- 2007-01-30 DE DE602007001779T patent/DE602007001779D1/de active Active
- 2007-01-30 UA UAA200810613A patent/UA88116C2/ru unknown
- 2007-01-30 AT AT07730888T patent/ATE437857T1/de active
- 2007-01-30 JP JP2008552845A patent/JP2009525311A/ja not_active Withdrawn
- 2007-01-30 PT PT07730888T patent/PT1979321E/pt unknown
- 2007-01-30 EA EA200801681A patent/EA015227B1/ru not_active IP Right Cessation
- 2007-01-30 KR KR1020087021424A patent/KR101050910B1/ko not_active IP Right Cessation
- 2007-01-30 EP EP07730888A patent/EP1979321B9/fr active Active
- 2007-01-30 MY MYPI20082681A patent/MY149068A/en unknown
- 2007-01-30 WO PCT/FR2007/000170 patent/WO2007085750A1/fr active Application Filing
- 2007-01-30 US US12/223,311 patent/US20100317698A1/en not_active Abandoned
- 2007-01-30 AU AU2007209235A patent/AU2007209235B2/en not_active Ceased
- 2007-01-30 ZA ZA200806399A patent/ZA200806399B/xx unknown
- 2007-01-30 CA CA2640482A patent/CA2640482C/fr not_active Expired - Fee Related
- 2007-01-30 GE GEAP200710875A patent/GEP20105090B/en unknown
- 2007-01-30 ES ES07730888T patent/ES2330899T3/es active Active
- 2007-01-30 SI SI200730068T patent/SI1979321T1/sl unknown
- 2007-01-30 PL PL07730888T patent/PL1979321T3/pl unknown
- 2007-01-30 BR BRPI0710443-0A patent/BRPI0710443A2/pt not_active IP Right Cessation
- 2007-01-30 CN CN2007800039160A patent/CN101374814B/zh not_active Expired - Fee Related
-
2008
- 2008-08-19 MA MA31181A patent/MA30222B1/fr unknown
- 2008-09-01 NO NO20083753A patent/NO20083753L/no not_active Application Discontinuation
-
2009
- 2009-05-11 HK HK09104298.2A patent/HK1126190A1/xx not_active IP Right Cessation
- 2009-09-29 HR HR20090523T patent/HRP20090523T1/hr unknown
- 2009-10-07 CY CY20091101033T patent/CY1109477T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0910503A2 (pt) | compostos, composições farmacêuticas e respectivos usos. | |
BRPI1010772A2 (pt) | composto,e, composição farmacêutica. | |
DK2107055T3 (da) | Dosmetinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
DK2101740T3 (da) | Nye ikke-misbrugs-farmaceutiske sammensætninger omfattende opioider | |
BRPI0918652A2 (pt) | Composições farmacêuticas e métodos de libração relacionadas. | |
BRPI1009372A2 (pt) | compostos, composição farmacêutica e respectivos usos | |
WO2009135646A3 (en) | Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale | |
DK2036892T3 (da) | 1,2,4,5-tetrahydro-3H-benzazepinforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
IL216113A (en) | Processed derivatives of indazole and azaza-indazole, pharmaceutical preparations containing them and their uses | |
BR112012003800A2 (pt) | composição, peptídeo, e formulação farmacêutica. | |
DK2254873T3 (da) | Benzodiazepinforbindelse og farmaceutisk sammensætning. | |
BR112012000831A2 (pt) | compostos, composições farmacêuticas e métodos relacionados | |
DK2281822T3 (da) | Nye dihydroindolonderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger, som indeholder disse | |
BRPI0907228A2 (pt) | Compostos de tienopiridazina, suas preparações, composições farmacêuticas e usos | |
BRPI0921507A2 (pt) | composição, método de preparação de um excipiente, comprimido farmacêutico e método de preparação do mesmo | |
DK2205105T3 (da) | Røgfri, oral tobakssammensætning og fremgangsmåder til fremstilling deraf | |
DK1953161T3 (da) | Nye tricykliske derivater, fremgangsmåde til fremstilling af samme og farmaceutiske sammensætninger indeholdende disse | |
DK1707564T3 (da) | Indanyl-piperazinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
DK2231598T3 (da) | Nye diazeniumdiolatderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
DK1742927T3 (da) | Butanonsyrederivater, fremgangsmåder til fremstilling deraf, farmaceutiske præparater omfattende dem, og farmaceutiske applikationer deraf | |
DK1979321T3 (da) | Nye pyridinylaminoalkylen- og pyridinyloxyalkylen-cyclopropanaminer, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende dissse | |
DK2987798T3 (da) | Trehalosederivater og farmaceutiske sammensætninger til behandling af neurodegenerative sygdomme, der indeholder disse | |
DK2094638T3 (da) | 2-aryl-2-fluorpropansyrer og derivater og farmaceutiske sammensætninger, der indeholder dem | |
DK2061807T3 (da) | MHC-oligomerer, bestanddele deraf og fremgangsmåder til fremstilling deraf | |
DK2432766T3 (da) | Anticancerforbindelse og farmaceutisk præparat, der indeholder den |